RAC Devices Exam UPDATED ACTUAL Questions and CORRECT Answers
Which of the following is a primary regulatory body for C) Food and Drug Administration
medical devices in the United States?
A) European Medicines Agency (EMA)
B) Medicines and Healthcare products Regulatory
Agency (MHRA)
C) Food and Drug Administration (FDA)
D) Therapeutic Goods Administration (TGA)
What is the purpose of a 510(k) submission? B) To demonstrate that a device is substantially equivalent to a legally marketed
A) To obtain premarket approval for a high-risk device device
B) To demonstrate that a device is substantially equivalent
to a legally marketed device
C) To apply for a CE mark for European market entry
D) To report adverse events related to a device
Which of the following is true about ISO 13485? C) It specifies requirements for a quality management system specific to medical
A) It is a standard for environmental management devices
systems
B) It provides guidelines for clinical trial design
C) It specifies requirements for a quality management
system specific to medical devices
D) It is a regulatory submission process for high-risk
devices
,What is required for a device to obtain CE marking? C) Demonstration of conformity with EU regulatory requirements
A) Approval from the FDA
B) A premarket notification (510(k))
C) Demonstration of conformity with EU regulatory
requirements
D) Submission of a clinical evaluation report to the FDA
Which risk management process involves identifying B) Risk Analysis
potential hazards associated with a medical device?
A) Risk Control
B) Risk Analysis
C) Risk Assessment
D) Risk Mitigation
Describe the difference between a Class I and a Class III Class I devices are considered low risk and typically require general controls (e.g.,
medical device. Provide examples of each. bandages). Class III devices are high risk and require premarket approval (e.g.,
pacemakers).
What are the key components of a Device Master Record Key components of a DMR include: production specifications, production process
(DMR)? specifications, quality assurance procedures, and packaging and labeling
requirements
Explain the significance of post-market surveillance in Post-marketing surveillance involves monitoring the device's performance and
regulatory affairs for medical devices. safety after it is on the market, including tracking adverse events and
implementing corrective actions (as needed).
Outline the steps involved in preparing a premarket Steps involved in a PMA application include:
approval (PMA) application. - pre-submission meetings with the FDA
- preparation of the PMA application (including clinical data)
-submission of the application
-FDA review
-potential approval with conditions
What is the role of an Institutional Review Board (IRB) in An IRB reviews and approves clinical trial protocols to ensure ethical standards
clinical trials for medical devices? and participant safety are maintained.
A medical device company is preparing to launch a new For the U.S. market: 510(k) submission or PMA depending on the risk classification.
infusion pump in the U.S. and European markets. The
company is seeking regulatory approval in both regions. For the European market: CE marking submission with a Notified Body.
Identify the regulatory submissions required for the U.S.
market and the European market.
, A medical device company is preparing to launch a new For the U.S. market, 510(k) or PMA documentation includes:
infusion pump in the U.S. and European markets. The -device description
company is seeking regulatory approval in both regions. -intended use
-substantial equivalence
Discuss the key considerations and documentation -clinical data
needed for each submission type. -manufacturing information.
For the European market, CE marking documentation includes:
-technical file
-clinical evaluation
-risk management file
-conformity assessment.
A medical device company is preparing to launch a new Post-market surveillance should include:
infusion pump in the U.S. and European markets. The -routine monitoring of device performance
company is seeking regulatory approval in both regions. -collection of adverse event reports
-implementation of corrective actions
Explain how the company should approach post-market
surveillance and reporting for both markets. Both markets require regular reporting of adverse events and updates to
regulatory bodies.
A medical device company is preparing to launch a new Challenges include differences in regulatory requirements and timelines. Solutions
infusion pump in the U.S. and European markets. The may involve consulting with regulatory experts in each region and ensuring
company is seeking regulatory approval in both regions. thorough and simultaneous preparation of submission documents.
Consider the potential challenges the company might
face in meeting regulatory requirements in both regions
and suggest solutions to address these challenges.
A medical device company is preparing to launch a new Risk management involves:
infusion pump in the U.S. and European markets. The -identifying potential hazards
company is seeking regulatory approval in both regions. -assessing risks
-implementing controls to mitigate those risks throughout the device lifecycle,
Describe the role of risk management in ensuring ensuring safety and compliance
compliance and safety of the infusion pump.
Which class of medical device generally requires the C) Class III
most stringent regulatory controls?
A) Class I Class III medical devices generally require the most stringent regulatory controls.
B) Class II These devices are considered high-risk and typically require premarket approval
C) Class III (PMA) from the FDA, which involves extensive clinical data to demonstrate their
D) Class IV safety and effectiveness. Examples of Class III devices include pacemakers and
heart valves.
Which of the following is a primary regulatory body for C) Food and Drug Administration
medical devices in the United States?
A) European Medicines Agency (EMA)
B) Medicines and Healthcare products Regulatory
Agency (MHRA)
C) Food and Drug Administration (FDA)
D) Therapeutic Goods Administration (TGA)
What is the purpose of a 510(k) submission? B) To demonstrate that a device is substantially equivalent to a legally marketed
A) To obtain premarket approval for a high-risk device device
B) To demonstrate that a device is substantially equivalent
to a legally marketed device
C) To apply for a CE mark for European market entry
D) To report adverse events related to a device
Which of the following is true about ISO 13485? C) It specifies requirements for a quality management system specific to medical
A) It is a standard for environmental management devices
systems
B) It provides guidelines for clinical trial design
C) It specifies requirements for a quality management
system specific to medical devices
D) It is a regulatory submission process for high-risk
devices
,What is required for a device to obtain CE marking? C) Demonstration of conformity with EU regulatory requirements
A) Approval from the FDA
B) A premarket notification (510(k))
C) Demonstration of conformity with EU regulatory
requirements
D) Submission of a clinical evaluation report to the FDA
Which risk management process involves identifying B) Risk Analysis
potential hazards associated with a medical device?
A) Risk Control
B) Risk Analysis
C) Risk Assessment
D) Risk Mitigation
Describe the difference between a Class I and a Class III Class I devices are considered low risk and typically require general controls (e.g.,
medical device. Provide examples of each. bandages). Class III devices are high risk and require premarket approval (e.g.,
pacemakers).
What are the key components of a Device Master Record Key components of a DMR include: production specifications, production process
(DMR)? specifications, quality assurance procedures, and packaging and labeling
requirements
Explain the significance of post-market surveillance in Post-marketing surveillance involves monitoring the device's performance and
regulatory affairs for medical devices. safety after it is on the market, including tracking adverse events and
implementing corrective actions (as needed).
Outline the steps involved in preparing a premarket Steps involved in a PMA application include:
approval (PMA) application. - pre-submission meetings with the FDA
- preparation of the PMA application (including clinical data)
-submission of the application
-FDA review
-potential approval with conditions
What is the role of an Institutional Review Board (IRB) in An IRB reviews and approves clinical trial protocols to ensure ethical standards
clinical trials for medical devices? and participant safety are maintained.
A medical device company is preparing to launch a new For the U.S. market: 510(k) submission or PMA depending on the risk classification.
infusion pump in the U.S. and European markets. The
company is seeking regulatory approval in both regions. For the European market: CE marking submission with a Notified Body.
Identify the regulatory submissions required for the U.S.
market and the European market.
, A medical device company is preparing to launch a new For the U.S. market, 510(k) or PMA documentation includes:
infusion pump in the U.S. and European markets. The -device description
company is seeking regulatory approval in both regions. -intended use
-substantial equivalence
Discuss the key considerations and documentation -clinical data
needed for each submission type. -manufacturing information.
For the European market, CE marking documentation includes:
-technical file
-clinical evaluation
-risk management file
-conformity assessment.
A medical device company is preparing to launch a new Post-market surveillance should include:
infusion pump in the U.S. and European markets. The -routine monitoring of device performance
company is seeking regulatory approval in both regions. -collection of adverse event reports
-implementation of corrective actions
Explain how the company should approach post-market
surveillance and reporting for both markets. Both markets require regular reporting of adverse events and updates to
regulatory bodies.
A medical device company is preparing to launch a new Challenges include differences in regulatory requirements and timelines. Solutions
infusion pump in the U.S. and European markets. The may involve consulting with regulatory experts in each region and ensuring
company is seeking regulatory approval in both regions. thorough and simultaneous preparation of submission documents.
Consider the potential challenges the company might
face in meeting regulatory requirements in both regions
and suggest solutions to address these challenges.
A medical device company is preparing to launch a new Risk management involves:
infusion pump in the U.S. and European markets. The -identifying potential hazards
company is seeking regulatory approval in both regions. -assessing risks
-implementing controls to mitigate those risks throughout the device lifecycle,
Describe the role of risk management in ensuring ensuring safety and compliance
compliance and safety of the infusion pump.
Which class of medical device generally requires the C) Class III
most stringent regulatory controls?
A) Class I Class III medical devices generally require the most stringent regulatory controls.
B) Class II These devices are considered high-risk and typically require premarket approval
C) Class III (PMA) from the FDA, which involves extensive clinical data to demonstrate their
D) Class IV safety and effectiveness. Examples of Class III devices include pacemakers and
heart valves.
